News

Newsletter

2023-04-28

Autotelic Bio, Dream CIS and Tigermed Signed an MOU for Mutual Cooperation for Global New Drug Development and Strategic Investment

Autotelic Bio and Yungjin Pharm. Entered Co-Development and Technical Implementation of Hypertension and Diabetic Combination Drug

Privacy Policy
Headquarter.#302, 194-41, Osong-saengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28610, Republic of Korea
R&D Center.#510 Signature Gwanggyo Knowledge Business Center 37, Poeun-daero 59beon-gil, Suji-gu, Yongin-si, Gyeonggi-do, 16864, Republic of Korea
- T.043-233-9373
- F.043-233-9374
- E.info@autotelic.co.kr